Automate Your Wheel Strategy on IQV
With Tiblio's Option Bot, you can configure your own wheel strategy including IQV - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol IQV
- Rev/Share 93.443
- Book/Share 36.9448
- PB 5.6301
- Debt/Equity 2.4659
- CurrentRatio 0.7028
- ROIC 0.0787
- MktCap 34702031000.0
- FreeCF/Share 15.5112
- PFCF 13.1447
- PE 27.0317
- Debt/Assets 0.5288
- DivYield 0
- ROE 0.214
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 4
- P/B Score 2
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Resumed | IQV | Morgan Stanley | -- | Overweight | -- | $265 | Dec. 2, 2025 |
| Initiation | IQV | BMO Capital Markets | -- | Outperform | -- | $260 | Nov. 13, 2025 |
| Downgrade | IQV | TD Cowen | Buy | Hold | -- | $215 | Nov. 3, 2025 |
| Upgrade | IQV | Robert W. Baird | Neutral | Outperform | -- | $258 | Oct. 29, 2025 |
| Upgrade | IQV | HSBC Securities | Hold | Buy | -- | $235 | Oct. 9, 2025 |
| Upgrade | IQV | Jefferies | Hold | Buy | -- | $225 | Sept. 9, 2025 |
| Downgrade | IQV | HSBC Securities | Buy | Hold | -- | $160 | April 25, 2025 |
| Downgrade | IQV | Barclays | Overweight | Equal Weight | -- | $170 | April 10, 2025 |
| Downgrade | IQV | BTIG Research | Buy | Neutral | -- | -- | Feb. 3, 2025 |
| Initiation | IQV | Stephens | -- | Overweight | -- | $250 | Dec. 20, 2024 |
News
IQV or IDXX: Which Is the Better Value Stock Right Now?
Published: February 04, 2026 by: Zacks Investment Research
Sentiment: Positive
Investors interested in Medical - Instruments stocks are likely familiar with IQVIA Holdings (IQV) and Idexx Laboratories (IDXX). But which of these two stocks is more attractive to value investors?
Read More
IQVIA Set to Report Q4 Earnings: Here's What You Should Know
Published: February 03, 2026 by: Zacks Investment Research
Sentiment: Positive
IQV is set to report fourth-quarter 2025 earnings results on Feb. 5, with revenues expected to rally 7.2% y/y to $4.2B and EPS to rise 9% on segment growth.
Read More
Unlocking Q4 Potential of IQVIA (IQV): Exploring Wall Street Estimates for Key Metrics
Published: February 03, 2026 by: Zacks Investment Research
Sentiment: Positive
Besides Wall Street's top-and-bottom-line estimates for IQVIA (IQV), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2025.
Read More
3 Medical Device Companies in Focus for Monetizing Data and Analytics
Published: January 15, 2026 by: Zacks Investment Research
Sentiment: Neutral
Medtronic, IQVIA and GE HealthCare show how medical device leaders are turning analytics, AI and enterprise data platforms into recurring revenue engines.
Read More
Why IQVIA Holdings (IQV) is a Top Momentum Stock for the Long-Term
Published: January 14, 2026 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Why IQVIA Holdings (IQV) is a Top Value Stock for the Long-Term
Published: January 09, 2026 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Here's Why You Should Retain IQV Stock in Your Portfolio Now
Published: December 29, 2025 by: Zacks Investment Research
Sentiment: Positive
IQVIA Holdings shares jump 25.5% in three months as AWS partnership, growing R&DS backlog and buybacks lift its earnings outlook.
Read More
IQVIA: Increasingly Indispensable In Drug Development
Published: December 11, 2025 by: Seeking Alpha
Sentiment: Positive
IQVIA Holdings is positioned as the indispensable data and technology backbone of the life sciences industry, far beyond a traditional CRO. Long-term revenue visibility is underpinned by a record $32.4B backlog, technology-driven margin expansion, and robust buyback-enhanced EPS growth. IQV's unique, comprehensive data assets and AI-enabled services create a defensible moat, insulating it from both Big Tech and CRO competition.
Read More
Why IQVIA Holdings (IQV) is a Top Momentum Stock for the Long-Term
Published: December 09, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Why Is IQVIA (IQV) Up 6.4% Since Last Earnings Report?
Published: November 27, 2025 by: Zacks Investment Research
Sentiment: Positive
IQVIA (IQV) reported earnings 30 days ago. What's next for the stock?
Read More
IQVIA Holdings Inc. (IQV) Presents at UBS Global Healthcare Conference 2025 Transcript
Published: November 11, 2025 by: Seeking Alpha
Sentiment: Neutral
IQVIA Holdings Inc. ( IQV ) UBS Global Healthcare Conference 2025 November 11, 2025 12:30 PM EST Company Participants Ari Bousbib - CEO & Chairman Conference Call Participants Daniel Leonard - UBS Investment Bank, Research Division Presentation Daniel Leonard UBS Investment Bank, Research Division All right. We're live.
Read More
IQVIA Holdings (IQV) is a Top-Ranked Value Stock: Should You Buy?
Published: November 05, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
IQVIA (IQV) Reports Q3 Earnings: What Key Metrics Have to Say
Published: October 28, 2025 by: Zacks Investment Research
Sentiment: Neutral
While the top- and bottom-line numbers for IQVIA (IQV) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Read More
IQVIA Earnings & Revenues Beat Estimates in Q3, Increase Y/Y
Published: October 28, 2025 by: Zacks Investment Research
Sentiment: Positive
IQV posts stronger-than-expected third-quarter 2025 earnings and revenue gains. It lifts the full-year guidance as all key segments show growth momentum.
Read More
IQVIA Holdings Inc. (IQV) Q3 2025 Earnings Call Transcript
Published: October 28, 2025 by: Seeking Alpha
Sentiment: Neutral
IQVIA Holdings Inc. (NYSE:IQV ) Q3 2025 Earnings Call October 28, 2025 9:00 AM EDT Company Participants Kerri Joseph - SVP of Investment Relation & Treasury Ari Bousbib - CEO & Chairman Ronald Bruehlman - Executive VP & CFO Michael Fedock - Senior Vice President of Financial Planning and Analysis Conference Call Participants David Windley - Jefferies LLC, Research Division Justin Bowers - Deutsche Bank AG, Research Division Elizabeth Anderson - Evercore ISI Institutional Equities, Research Division Michael Cherny - Leerink Partners LLC, Research Division Shlomo Rosenbaum - Stifel, Nicolaus & Company, Incorporated, Research Division Eric Coldwell - Robert W. …
Read More
IQVIA Holdings (IQV) Tops Q3 Earnings and Revenue Estimates
Published: October 28, 2025 by: Zacks Investment Research
Sentiment: Positive
IQVIA Holdings (IQV) came out with quarterly earnings of $3 per share, beating the Zacks Consensus Estimate of $2.96 per share. This compares to earnings of $2.84 per share a year ago.
Read More
ILMN Stock vs. IQV Stock
Published: September 26, 2025 by: Forbes
Sentiment: Negative
Amid increased competition from China's MGI Tech, Illumina's stock (NASDAQ: ILMN) has dropped by 11% in a week. MGI Tech's DNA sequencers are reportedly gaining market share, and despite a recent decline in its international sales due to U.S. sanctions, MGI Tech's global market presence remains strong.
Read More
Here's Why IQVIA Holdings (IQV) is a Strong Value Stock
Published: September 19, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Here's Why IQVIA Holdings (IQV) is a Strong Value Stock
Published: September 03, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
IQVIA names Michael Fedock as financial chief
Published: September 02, 2025 by: Reuters
Sentiment: Positive
IQVIA Holdings on Tuesday named insider Michael Fedock as Chief Financial Officer, effective February 28, 2026, succeeding Ron Bruehlman who is set to retire.
Read More
The Big 3: BLDR, IQV, LOW
Published: August 19, 2025 by: Schwab Network
Sentiment: Positive
Jessica Inskip expects Jackson Hole this week to be a big market mover. She also sees a potential path for interest rates during the meeting adding momentum to the homebuilder space, including Builders FirstSource (BLDR).
Read More
Why IQVIA Holdings (IQV) is a Top Value Stock for the Long-Term
Published: August 14, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
IQVIA (IQV) Reliance on International Sales: What Investors Need to Know
Published: July 28, 2025 by: Zacks Investment Research
Sentiment: Neutral
Explore IQVIA's (IQV) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
Read More
IQVIA Holdings Inc. (IQV) Q2 2025 Earnings Call Transcript
Published: July 22, 2025 by: Seeking Alpha
Sentiment: Neutral
IQVIA Holdings Inc. (NYSE:IQV ) Q2 2025 Earnings Conference Call July 22, 2025 9:00 AM ET Company Participants Ari Bousbib - CEO & Chairman Kerri Joseph - Corporate Participant SVP of Investment Relation & Treasury - Corporate Participant Ronald E. Bruehlman - Executive VP & CFO Conference Call Participants Ann Kathleen Hynes - Mizuho Securities USA LLC, Research Division Christine Rains - William Blair & Company L.L.C.
Read More
IQVIA Earnings & Revenues Beat Estimates in Q2, Rise Y/Y
Published: July 22, 2025 by: Zacks Investment Research
Sentiment: Positive
IQV tops second-quarter 2025 estimates, with earnings up 6.4% and revenue rising 5.5%. It cuts the 2025 EBITDA guidance.
Read More
IQVIA Holdings (IQV) Q2 Earnings and Revenues Surpass Estimates
Published: July 22, 2025 by: Zacks Investment Research
Sentiment: Positive
IQVIA Holdings (IQV) came out with quarterly earnings of $2.81 per share, beating the Zacks Consensus Estimate of $2.76 per share. This compares to earnings of $2.64 per share a year ago.
Read More
IQVIA Gears Up to Report Q2 Earnings: What's in Store for the Stock?
Published: July 16, 2025 by: Zacks Investment Research
Sentiment: Positive
IQV is set to report Q2 results on July 22, with both earnings and revenues expected to rise on strong demand across segments.
Read More
IQVIA Holdings (IQV) Earnings Expected to Grow: Should You Buy?
Published: July 15, 2025 by: Zacks Investment Research
Sentiment: Neutral
IQVIA (IQV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read More
Why IQVIA Holdings (IQV) is a Top Growth Stock for the Long-Term
Published: July 11, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
IQVIA Stock: Stuck In A Time Spiral - Value Play Or Bull Trap?
Published: June 10, 2025 by: Benzinga
Sentiment: Neutral
IQVIA (IQV) is currently in Phase 18 of its 18-Phase Adhishthana Cycle. On the surface, the stock might appear poised for a new move, but when analyzed through a multi-timeframe lens using the Adhishthana Principles, the picture is more complex.
Read More
About IQVIA Holdings Inc. (IQV)
- IPO Date 2013-05-09
- Website https://www.iqvia.com
- Industry Medical - Diagnostics & Research
- CEO Ari Bousbib
- Employees 89000